Is bilobectomy superior to lobectomy in treating non-small cell lung cancer (NSCLC) of the right lower lung field?

Lung Cancer ◽  
1994 ◽  
Vol 11 ◽  
pp. 166
Author(s):  
Biing-Shiun Huang ◽  
Ching-Yuan Cheng ◽  
Wen-Hu Hsu ◽  
Liang-Shun Wang ◽  
Min-Hsiung Huang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Field ◽  
Small Cell Lung ◽  
Lower Lung Field ◽  
Lower Lung ◽  
The Right

A Man Presenting with Sudden Weakness and Pain of the Right Hand, by Non-Small Cell Lung Cancer with Brain Metastases

Clinical Pain ◽  
2019 ◽  
Vol 18 (2) ◽  
pp. 88-91
Author(s):  
Won Jin Sung ◽  
Bo Young Hong ◽  
Joon Sung Kim ◽  
Jae Wan Yoo ◽  
Seong Hoon Lim
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Right Hand ◽  
The Right

scholarly journals Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report

Immunotherapy ◽  
2020 ◽  
Author(s):  
Yasuhiro Kato ◽  
Yasutaka Watanabe ◽  
Yuki Yamane ◽  
Hideaki Mizutani ◽  
Futoshi Kurimoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Checkpoint Inhibitors ◽  
Chest Ct ◽  
Small Cell ◽  
Small Cell Lung ◽  
Intermittent Fever ◽  
Unresectable Stage ◽  
The Right

Background: Tuberculosis (TB) is considered to be an adverse effect of treatment with immune checkpoint inhibitors. Methodology & results: Our case was a 75-year-old woman diagnosed with unresectable stage III non-small-cell lung cancer. After radical chemoradiotherapy was completed, durvalumab was initiated as a consolidation therapy. However, since chest CT showed appearances of infiltration shadows scattered in the periphery of the lungs after five doses of immunotherapy, duruvalumab was discontinued. 6 weeks later, the patient was aware of intermittent fever. Chest CT scan showed the appearance of a tree-in-bud pattern in the right lung. Acid-fast bacilli stain of sputum was positive and the PCR test was positive for Mycobacterium tuberculosis. Conclusion: Duruvalumab as PD-L1 blockade may activate TB.

scholarly journals Metastatic Ureteral Involvement of Non-Small Cell Lung Cancer

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Koichi Kodama ◽  
Tetsuya Imao ◽  
Kazuto Komatsu
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Malignant Tumors ◽  
Lower Lobe ◽  
Small Cell ◽  
Small Cell Lung ◽  
Primary Tumors ◽  
The Right

Metastases from a variety of malignant tumors can involve the ureters, but ureteral involvement by lung cancer is extremely rare and usually described at autopsy. We report a rare case of a 76-year-old man who presented with a three-month history of right flank dullness and was noted to have a nonhomogeneous retroperitoneal mass with hydronephrosis of the right kidney on computed tomography of the abdomen. Computed tomography of the thorax showed a nodule in the lower lobe, measuring3×2 cm, in the right lung. After excluding the presence of other primary tumors and metastases, we reached a final diagnosis of solitary retroperitoneal metastasis of adenocarcinoma of the lung. Although rare, in patients of non-small cell lung cancer, presence of hydronephrosis should alert the physician to the possibility of metastasis.

Sign in / Sign up

Export Citation Format

Share Document